In the FINRISK study cohorts there was an increasing trend in the prevalence of CVD from 9.0% in the normoglycemic group to 34.8% in patients with known T2DM.
← all excerpts
Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.
1
—
—